Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
about
In vitro effects of folate inhibitors on Toxoplasma gondiiSevere falciparum malaria. World Health Organization, Communicable Diseases ClusterPharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.Evaluation of effects of altered gastric pH on absorption of dapsone in healthy volunteers.Disposition of intravenous pyrimethamine in healthy volunteers.Dapsone in dermatology and beyondThe pharmacokinetics of dapsone after oral administration to healthy volunteers.Salivary elimination of pyrimethamine.Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine.ELISA tests for dapsone and pyrimethamine and their application in a malaria chemoprophylaxis programme.Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods.Drug treatment and prevention of malaria.Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection.Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis.Multiple-dose pharmacokinetics and in vitro antimalarial activity of dapsone plus pyrimethamine (Maloprim) in man.Oxidative activation of proguanil and dapsone acetylation in Thai soldiers.Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy.Prediction of Transporter-Mediated Drug-Drug Interactions for Baricitinib.
P2860
Q28342121-9AE9BB16-D59D-4404-AD59-C66CB2203045Q29614923-11B00F23-3339-415B-9DFA-41820E07A335Q33754929-8237FA8C-35CD-417A-BC09-C443A33A6C39Q33760167-990D01E5-3682-42D2-9A40-715B56B51B80Q33979823-D79C4220-21C9-44E4-BF2F-B5D7448B30D4Q34390020-FE1EA234-4F8C-4D72-9F60-D20AC602EF1CQ34448048-C3A21B2B-35B3-484F-950E-93163BE1CC61Q34448826-1942CB8A-AA1D-4C3F-BB6C-27D9BFB22739Q36752819-50779D86-A6D3-419E-A4D4-3957A1248C0EQ36799248-E7F68DF2-9676-4FFD-B975-0E8EE24B0480Q38627882-0EC6270C-60D9-4AB0-A745-D2F5BE33E8A8Q39590158-D3ABAE81-59A8-422B-8AC4-CE1D651DABE1Q39782074-3FE27912-2042-40F5-B36A-FD859A4AC805Q40165651-C421ACFC-3C71-42DE-B299-30E291725BFFQ41943556-59CB31D0-EF7D-4784-9E92-F744A3C8B820Q42002911-D3057926-DFB2-4F49-BE50-EE8DCFBE0CBFQ43272249-AFF9A927-984E-40D9-B025-8EC23F061448Q46119650-74818B8B-6F77-43E5-9595-FDFD48F84E3D
P2860
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
description
1980 nî lūn-bûn
@nan
1980 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
@ast
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
@en
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
@nl
type
label
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
@ast
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
@en
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
@nl
prefLabel
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
@ast
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
@en
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
@nl
P2860
P1476
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1980.TB01798.X
P407
P577
1980-11-01T00:00:00Z